Pfizer Inc. buy BMO Capital Markets
Start price
23.06.26
/
50%
€21.91
Target price
23.06.27
-
Performance (%)
-3.06%
Price
19:13
€21.24
Summary
This prediction is currently active. With a performance of -3.06%, the BUY prediction for Pfizer Inc. by BMO_Capital_Markets is down slightly. This prediction currently runs until 23.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pfizer Inc. | 3.639% |
| iShares Core DAX® | -3.173% |
| iShares Nasdaq 100 | -1.006% |
| iShares Nikkei 225® | -3.600% |
| iShares S&P 500 | 0.214% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat